Abstract
Phyllodes tumors of the breast, rare fibroepithelial lesions, present unique challenges due to their potential for local recurrence and metastasis. While surgical excision is the primary treatment modality, achieving clear margins does not always guarantee prevention of recurrence. Factors such as tumor histology and pathologic features influence recurrence rates, with borderline and malignant tumors being at higher risk. Adjuvant therapies, particularly radiotherapy, show promise in improving local control, but their efficacy remains under investigation. Continued research is essential to identify predictive factors for recurrence and to refine treatment strategies for recurrent phyllodes, ultimately minimizing their impact on patients and healthcare professionals. This article presents two cases of recurrent phyllodes tumors and underscores the need for further exploration into the management of recurrent phyllodes tumors and highlights the ongoing challenges in mitigating their recurrence and improving patient outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have